Other Items

DOCUMENTS

Clot Busters !! – Discovery of Thrombolytic Therapy for Heart Attack and Stroke

“Breakthroughs in Bioscience” issue of the FASEB (Federation of American Societies for Experimental Biology), published in 2004.

The TOP 100 living Contributors to Biotechnology, 2005

Reed Exhibitions, a division of Reed Elsevier conducted an independent poll among senior staff throughout the biotechnology industry to identify the most influential and inspirational pioneers. An alphabetic list of the TOP 100 living  contributors was produced.

A list of highly influential biomedical researchers, 1996-2011

Boyak K.W., Klavans R., Sorensen A.A., Ioannidis J.P.A. Eur J Clin Invest 43, 1339-1365, 2013.
A list of highly influential biomedical researchers was generated based on Scopus citation data from the period 1996‐2011. The top‐400 living core biomedical researchers were selected based on a normalized score combining total citations and h‐index.

A Citation Perspective on high Impact Research Authors, 1992

Garfield E., Welljams-Dorof A. Current Contents 35, August 31, 1992.
A list of the 100 most-cited authors of articles published and cited in 1981-1990. Désiré

Collen ranked 50th and is the only listed author in the field of hematology.

International Society for Fibrinolysis and Thrombolysis (ISFT), 1992

The International Society for Fibrinolysis and Thrombolysis (ISFT) was constituted in 1992 with an endowment of $50,000 from LSRP (DCRF), with D. Collen as first Chairman. It is now renamed as International Society for Fibrinolysis and Proteolysis (ISFP). It was recognized as a non-profit organization with bylaws published in the “Belgisch Staatsblad” of July 26, 2001, and with registered office at Campus Gasthuisberg in Leuven.

“The objectives of the Society; which has no profit motive, are exclusively scientific and educational in nature.  Specifically, the objectives include the furtherance of scientific research relating to fundamental and medical aspects of fibrinolysis, proteolysis and thrombolysis”.

ISFT-Congress Leuven, 1994

The XIIth International Congress on Fibrinolysis, under the auspices of the International Society for Fibrinolysis and Thrombolysis (ISFT), was organized by the Center for Thrombosis and Vascular Research in Leuven, September 18-22, 1994, under the presidency of D. Collen. At that time, the ISFT had over 400 members from 35 countries.

Prospectus IPO ThromboGenics June 2006